Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Selmin Ataergin"'
Publikováno v:
Case Reports in Medicine, Vol 2009 (2009)
18F-FDG PET is a useful and sensitive imaging method for a variety of malignancies, however, the specificity is low in active infections and inflammatory diseases. We describe a female patient with stage IIIA breast cancer in first complete remission
Externí odkaz:
https://doaj.org/article/cfcd9e23251d4497a03cbd1257d68b06
Autor:
Selmin Ataergin, Fikret Arpaci, Kaan Erler, Bahtiyar Demiralp, Ilker Cicek, Cuneyt Ulutin, Luis Solchaga, Ayhan Ozcan
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 1 (2007)
We present a 20-year-old male patient with localized osteosarcoma arising in osteogenesis imperfecta who underwent high-dose chemotherapy together with autologous peripheral blood stem cell transplantation followed-by a successful extremity sparing s
Externí odkaz:
https://doaj.org/article/5451cbed1b8940a4adf40cae2d248ae0
Autor:
Mustafa Öztürk, Gokhan Erdem, Gürkan Mert, Ramazan Gümral, Fikret Arpaci, Nuri Karadurmus, Ismail Erturk, Sukru Ozaydin, Birol Yildiz, Selmin Ataergin
Publikováno v:
British Journal of Medicine and Medical Research. 19:1-5
Autor:
Mukerrem Safali, Mustafa Ozturk, Selmin Ataergin, Gokhan Erdem, Sukru Ozaydin, Ozdes Emer, Nuri Karadurmus, Fikret Arpaci, Mustafa Cakar
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
The central nervous system (CNS) is an important area of involvement for both high-grade, aggressive primary and secondary lymphomas. Although follicular lymphoma represents a low-grade histology, it may rarely present with CNS involvement. Here, we
Autor:
Bekir Öztürk, Ahmet Özet, Mustafa Ozturk, Mehmet Ozler, Fikret Arpaci, Turgut Topal, Mehmet Yasar, Okan Kuzhan, Yesim Oztas, Yasemin Gulcan Kurt, Bulent Kurt, Bulent Uysal, Nail Ersoz, Cengizhan Acikel, Seref Demirbas, Sukru Oter, Ahmet Korkmaz, Selmin Ataergin
Publikováno v:
Journal of Pineal Research. 50:89-96
Doxorubicin (DOX) and Trastuzumab (TRAST) are effective agents for the treatment of many neoplastic diseases. Cardiotoxicity is a major side effect of these drugs and limit their use. In this study, the possible protective effects of melatonin (MEL),
Autor:
David I. Marks, Jeanette Carreras, Jane N. Winter, Robert Peter Gale, Santiago Pavlovsky, Shimon Slavin, Thomas C. Shea, Koen van Besien, Julie M. Vose, Asli Selmin Ataergin, Richard T. Maziarz, Thomas R. Klumpp, Brandon Hayes-Lattin, Mei-Jie Zhang, Parameswaran Hari, David J. Inwards, Steven C. Goldstein, Gregory A. Hale, Jacob D. Bitran, Philip L. McCarthy, Harry C. Schouten, Cesar O. Freytes, J. Douglas Rizzo, Brian J. Bolwell, Hillard M. Lazarus
Publikováno v:
Biology of Blood and Marrow Transplantation, 16(1), 35-45. Elsevier Science
We compared outcomes of 916 diffuse large B cell lymphoma (DLBCL) patients aged >or=18 years undergoing first autologous (n = 837) or myeloablative (MA) allogeneic hematopoietic cell transplant (HCT) (n = 79) between 1995 and 2003 reported to the Cen
Autor:
Serdar Surenkok, Ahmet Özet, Mustafa Turan, Luis A. Solchaga, Murat Beyzadeoglu, Şeref Kömürcü, Kaan Oysul, Fikret Arpaci, Selmin Ataergin, Mustafa Ozturk
Publikováno v:
Medical Oncology. 26:276-286
The outcome of Ewing's sarcoma depends on the anatomical site of the tumor. Studies conducted in high-risk patients are limited. We evaluated the outcome of high-risk Ewing's sarcoma patients that received long-term treatment protocol. Twenty-five pa
Autor:
Ahmet Özet, Mustafa Turan, Luis A. Solchaga, Bekir Öztürk, Türker Çetin, Mustafa Ozturk, Fikret Arpaci, Selmin Ataergin, Şeref Kömürcü
Publikováno v:
American Journal of Hematology. 83:644-648
In vitro studies have demonstrated a 27% increased efficacy of lenograstim over filgrastim. However, equal doses of 10 microg/kg/day of filgrastim and lenograstim have been recommended for mobilization of CD34+ cells without associated chemotherapy.
Autor:
Cengiz Yakicier, Fikret Arpaci, Türker Çetin, Şefik Güran, Murat Beyzadeoglu, Ahmet Özet, Selmin Ataergin
Publikováno v:
American Journal of Hematology
A 38‐year‐old female with chronic myeloid leukemia underwent an allogeneic bone marrow transplantation from her full‐matched brother. Eleven months later, she readmitted with an acute leukemia that was shown to be of donor origin. The patient n
Autor:
Şeref Kömürcü, Okan Kuzhan, Selmin Ataergin, Türker Çetin, Bekir Öztürk, Ahmet Özet, Fikret Arpaci, Aysel Pekel, Kaan Oysul
Publikováno v:
Journal of Clinical Apheresis. 19:197-201
This prospective study was carried out in healthy donors and patients. The performance of the CliniMACS was evaluated with the comparison of the numbers of total nucleated cell (TNC) within and over the capacity of the normal scale column. In additio